comparemela.com

Latest Breaking News On - Moleculin biotech inc - Page 24 : comparemela.com

JTC Team, LLC: JTC Team Announces Presenting Company Line-Up for the Virtual Investor Summer Spotlight Series

JTC Team, LLC: JTC Team Announces Presenting Company Line-Up for the Virtual Investor Summer Spotlight Series
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

StockNews com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)

StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report report published on Friday morning. The firm issued a sell rating on the stock. Other analysts have also recently issued reports about the stock. Oppenheimer restated an outperform rating and set a $5.00 price target on shares of Moleculin […]

Moleculin Biotech (NASDAQ:MBRX) Earns Sell Rating from Analysts at StockNews com

StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report report published on Friday morning. The firm issued a sell rating on the stock. Several other research analysts also recently weighed in on the stock. Oppenheimer reissued an outperform rating and issued a $5.00 target price on shares of […]

Moleculin Biotech, Inc (NASDAQ:MBRX) Sees Significant Growth in Short Interest

Moleculin Biotech, Inc. (NASDAQ:MBRX – Free Report) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 16,700 shares, a growth of 108.8% from the May 31st total of 8,000 shares. Based on an average daily trading volume, of 269,900 shares, […]

Moleculin Biotech (NASDAQ:MBRX) Research Coverage Started at StockNews com

StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a report published on Thursday morning. The brokerage issued a sell rating on the stock. A number of other equities research analysts also recently commented on MBRX. Roth Mkm reiterated a buy rating and set a $16.00 price target on shares of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.